News
Advanz Pharma and Alvotech announced AVT06, a biosimilar to Eylea, was approved for neovascular age-related macular ...
Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback